NIH, BARDA Seek Out New Point-Of-Care Diagnostics For RADx Program To Boost US COVID-19 Testing
The US National Institutes of Health and the Biomedical Advanced Research and Development Authority are asking manufacturers to provide new COVID-19 diagnostic candidates for NIH’s Rapid Acceleration of Diagnostics (RADx) program.
You may also be interested in...
The US NIH has awarded seven contracts worth tens of millions of dollars each to companies making rapid point-of-care (POC) and lab-based coronavirus tests
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.
At two recent confirmation hearings, HHS secretary nominee Xavier Becerra promised Senators he would help expand telehealth and procedure price transparency.